Zoetis Inc. (NYSE:ZTS) Stake Boosted by TCV Trust & Wealth Management Inc.

TCV Trust & Wealth Management Inc. lifted its stake in shares of Zoetis Inc. (NYSE:ZTS) by 1.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 78,401 shares of the company’s stock after purchasing an additional 1,217 shares during the quarter. TCV Trust & Wealth Management Inc.’s holdings in Zoetis were worth $12,774,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in the stock. Darwin Wealth Management LLC acquired a new stake in Zoetis in the third quarter worth $31,000. First Personal Financial Services bought a new position in shares of Zoetis during the third quarter worth about $33,000. Capital Performance Advisors LLP acquired a new stake in shares of Zoetis in the 3rd quarter worth about $33,000. Dunhill Financial LLC lifted its position in Zoetis by 80.6% in the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock valued at $33,000 after purchasing an additional 75 shares during the last quarter. Finally, Atlantic Edge Private Wealth Management LLC boosted its stake in Zoetis by 482.8% during the 4th quarter. Atlantic Edge Private Wealth Management LLC now owns 169 shares of the company’s stock valued at $28,000 after purchasing an additional 140 shares during the period. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Leerink Partners started coverage on shares of Zoetis in a research note on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price target on the stock. Morgan Stanley lowered their target price on Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 29th. UBS Group initiated coverage on Zoetis in a research note on Monday, December 9th. They set a “neutral” rating and a $196.00 target price on the stock. Piper Sandler decreased their price target on Zoetis from $210.00 to $200.00 and set an “overweight” rating for the company in a research note on Monday. Finally, Stifel Nicolaus cut their price objective on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Zoetis presently has an average rating of “Buy” and an average target price of $214.00.

Insider Transactions at Zoetis

In related news, EVP Roxanne Lagano sold 326 shares of Zoetis stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $171.18, for a total value of $55,804.68. Following the transaction, the executive vice president now directly owns 16,107 shares in the company, valued at $2,757,196.26. The trade was a 1.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.16% of the company’s stock.

Zoetis Trading Up 1.5 %

Shares of ZTS stock opened at $174.47 on Wednesday. The stock has a 50-day simple moving average of $169.16 and a 200 day simple moving average of $179.15. The stock has a market capitalization of $78.72 billion, a P/E ratio of 32.80, a P/E/G ratio of 2.77 and a beta of 0.90. Zoetis Inc. has a fifty-two week low of $144.80 and a fifty-two week high of $200.53. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26.

Zoetis Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 3rd. Stockholders of record on Monday, April 21st will be given a dividend of $0.50 per share. The ex-dividend date is Monday, April 21st. This represents a $2.00 annualized dividend and a dividend yield of 1.15%. Zoetis’s dividend payout ratio (DPR) is 37.59%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.